Product Information
FOSINOPRIL SODIUM 10 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.1542 per EA under NDC 69097085605. Its NADAC has been published 530 times since Aug 10, 2016.
FDA first approved this application on Apr 20, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Cipla USA Inc.NDC
69097085605
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FOSINOPRIL SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA077222FDA Approved
4/20/2005
TE Code
AB
On Market Since
6/16/2016
Pharmacological Classes
Price Statistics
The NADAC for FOSINOPRIL SODIUM 10 MG TAB has been published 530 times since Aug 10, 2016, and over the history we have for it it has risen 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1542 per EA |
|---|---|
| All-time high | $0.1827 (Sep 15, 2021) |
| All-time low | $0.1089 (Apr 18, 2018) |
| 52-week high | $0.1744 |
| 52-week low | $0.1474 |
| Median price | $0.1555 |
| Average price | $0.1537 |
| Largest weekly change | -25.6% (Apr 18, 2018) |
| Weeks tracked | 530 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fosinopril market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fosinopril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FOSINOPRIL SODIUM 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FOSINOPRIL SODIUM 10 MG TAB, manufactured by Cipla USA Inc., is $0.1542 per EA (NDC 69097085605), effective Sep 30, 2026.
How has the price of FOSINOPRIL SODIUM 10 MG TAB changed over time?
Over the history we have for it, the NADAC for FOSINOPRIL SODIUM 10 MG TAB has risen 11.4%. It has been tracked across 530 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for FOSINOPRIL SODIUM 10 MG TAB?
Since Aug 10, 2016, the NADAC for FOSINOPRIL SODIUM 10 MG TAB has ranged from a low of $0.1089 (Apr 18, 2018) to a high of $0.1827 (Sep 15, 2021), with a median of $0.1555 per EA.
Are there cheaper alternatives to FOSINOPRIL SODIUM 10 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of FOSINOPRIL SODIUM 10 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FOSINOPRIL SODIUM 10 MG TAB?
FOSINOPRIL SODIUM 10 MG TAB (NDC 69097085605) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.